Ad
related to: fda nitrosamine
Search results
To Avoid Supply Crunch, FDA Temporarily Allows Higher Impurity Levels In Merck's Diabetes Drug:...
Benzinga via Yahoo Finance· 2 years agoThe FDA recently became aware of a nitrosamine impurity, Nitroso-STG-19 or NTTP, in certain samples...
Blood pressure medicine recall: Some pills pose potential cancer risk, FDA announces
USA TODAY via Yahoo News· 1 year agoA pharmaceutical company is recalling a blood pressure medication due to a potential cancer risk,...
FDA Issues No Action Notice For Phathom Pharma's Investigational Candidate, Shares Plunge
Benzinga via Yahoo Finance· 1 year agoThe FDA notified Phathom Pharmaceuticals Inc (NASDAQ: PHAT) that no action would be taken on the...
FDA recalls blood pressure medication over cancer risks
The Hill via Yahoo News· 1 year agoLupin Pharmaceuticals Inc. is recalling four lots of its blood pressure medication, Quinapril...
Another pharmaceutical company has recalled blood pressure medication over illness risk
Miami Herald via AOL· 1 year agoAnother pharmaceutical company is recalling a blood pressure medication that could increase the risk...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
Phathom Pharma Shares Fall After Formal FDA Request For Vonoprazan Data
Benzinga via Yahoo Finance· 1 year agoThe FDA has formally asked for additional stability data to demonstrate that levels of the impurity...
Stroke and blood clot drug recalled for an impurity volume that can increase cancer risk
Miami Herald via Yahoo News· 1 year agoAscend Laboratories has recalled 10 lots of Dabigatran Etexilate capsules, used to lower the risk of...
Blood pressure tablets recalled over potential cancer risk, FDA announces
USA TODAY via Yahoo News· 1 year agoFour lots of the blood pressure medication Quinapril were voluntarily recalled last week by drug...
Phathom (PHAT) Down on Regulatory Update on Vonoprazan NDA
Zacks via Yahoo Finance· 1 year agoPhathom Pharmaceuticals, Inc. (PHAT) declines as the FDA decides to not take any action on Phathom's...
